https://european-biotechnology.com/wp-content/uploads/2024/04/Altdorfer.jpg7061068Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-04-20 19:46:482021-04-20 19:46:48Record year for Swiss biotech industry
The European Union has exercised its option to order 100 million additional doses of BNT162b2 bringing its orders to 600 million doses at €14.70 per shot.
No matter whether you’re an end user or an OEM in biophotonics, biomedical optics, and imaging, Coherent has the laser that perfectly matches your needs and your budget.
A new study on the persistence of neutralising antibodies to SARS-CoV-2 in the blood suggests that humoral immunity will drop 5 months after vaccination.
Francesco Maria Lavino has been appointed as Chief Executive Officer of F2G Ltd., a biopharmaceutical company, based in UK and Austria, and specialised in fungal infections.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2021-04-14 12:13:462021-04-14 12:13:46Change in Management
Swiss BioVersys has received €20mfrom the European Investment Bank to push the development of new drugs against life-threatening nosocomial infections.
Endeavour Medtech Growth II LP closes at $375m
Latest NewsEndeavour Vision has announced the closing of its Heathtech fund Endeavour Medtech Growth II (EMG II) LP at US$375 million in capital commitments.
Record year for Swiss biotech industry
Latest NewsThe Swiss biotech industry experienced a record investment in the pandemic year 2020, according to the new Swiss Biotech Report.
EU orders 100 million additional doses from Biontech
Latest NewsThe European Union has exercised its option to order 100 million additional doses of BNT162b2 bringing its orders to 600 million doses at €14.70 per shot.
Lasers for Biomedical Optics and Imaging Applications
Sponsored PublicationsNo matter whether you’re an end user or an OEM in biophotonics, biomedical optics, and imaging, Coherent has the laser that perfectly matches your needs and your budget.
COVID-19: Study finds neutralising antibodies to disappear rapidly
Latest NewsA new study on the persistence of neutralising antibodies to SARS-CoV-2 in the blood suggests that humoral immunity will drop 5 months after vaccination.
Change in Management
AppointmentsFrancesco Maria Lavino has been appointed as Chief Executive Officer of F2G Ltd., a biopharmaceutical company, based in UK and Austria, and specialised in fungal infections.
BioVersys gets €20m EIB loan to develop novel antibiotics
Latest NewsSwiss BioVersys has received €20mfrom the European Investment Bank to push the development of new drugs against life-threatening nosocomial infections.
C4X Discovery and Sanofi ink €414m IL-17A blocker R&D contract
Latest NewsC4X Discovery Holdings plc has licenced its oral C4XD oral IL-17A inhibitor programme to Sanofi.
C4X Discovery and Sanofi ink €414m IL-17A blocker R&D contract
Latest NewsC4X Discovery Holdings plc has licenced its oral C4XD oral IL-17A inhibitor programme to Sanofi.
C4X Discovery and Sanofi ink €414m IL-17A blocker R&D contract
Latest NewsC4X Discovery Holdings plc has licenced its oral C4XD oral IL-17A inhibitor programme to Sanofi.